ARTIVION (AORT) director receives 7,576-share stock grant, lifting holdings to 34,765

Rhea-AI Filing Summary

Hoff Elizabeth A reported acquisition or exercise transactions in this Form 4 filing.

ARTIVION, INC. director Elizabeth A. Hoff reported receiving a grant of 7,576 shares of common stock as equity compensation. The shares were awarded at no cash cost per share and increased her directly held position to 34,765 shares. According to the footnote, this restricted stock award is scheduled to vest on May 18, 2027 under the company’s Equity and Cash Incentive Plan, meaning she will fully earn the shares over time if vesting conditions are met.

Insights

Equity Compensation Analyst

Routine director equity grant with time-based vesting, neutral signal.

Director Elizabeth A. Hoff received 7,576 shares of ARTIVION common stock as an equity award, bringing her direct holdings to 34,765 shares. The transaction code A marks this as a grant or award, not an open-market purchase.

The footnote states this RSA grant vests on May 18, 2027 under the Equity and Cash Incentive Plan, indicating time-based vesting typical for director compensation. There is no sale or derivative exercise activity disclosed here.

Because this is a standard compensation grant without accompanying sales or large position changes, it is best viewed as an administrative update rather than a directional signal about the company’s prospects.

Insider Trade Summary

Net Buyer: 7,576 shares

Net Buy 1 txn

Insider Hoff Elizabeth A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,576	$0.00	$0.00

Holdings After Transaction: Common Stock — 34,765 shares (Direct)

Footnotes (1)

1. F1. RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

Key Figures

Shares granted: 7,576 shares Grant price: $0.00 per share Holdings after grant: 34,765 shares +4 more

7 metrics

Shares granted 7,576 shares Restricted stock award to director on May 18, 2026

Grant price $0.00 per share Equity compensation, no cash paid by director

Holdings after grant 34,765 shares Director’s direct ownership following the transaction

Transaction code A Grant, award, or other acquisition of common stock

Transaction direction acquire Non-derivative award increasing share holdings

Vesting date May 18, 2027 RSA grant vests under Equity and Cash Incentive Plan

Security type Common Stock Non-derivative equity security granted

Key Terms

RSA Grant, Equity and Cash Incentive Plan, restricted stock award, Form 4

4 terms

RSA Grant financial

"RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan."

Equity and Cash Incentive Plan financial

"RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan."

restricted stock award financial

"According to the footnote, this restricted stock award is scheduled to vest on May 18, 2027 under the company’s Equity and Cash Incentive Plan,"

A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.

Form 4 regulatory

"What did ARTIVION (AORT) director Elizabeth Hoff report in this Form 4?"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 05/20/2026 - 08:33 PM Learn about SEC filing dates

FAQ

What did ARTIVION (AORT) director Elizabeth Hoff report in this Form 4?

Elizabeth A. Hoff reported receiving a grant of 7,576 ARTIVION common shares. The award was recorded at no cash cost per share and represents routine equity compensation, increasing her directly held stake to 34,765 shares after the transaction.

Was the ARTIVION (AORT) Form 4 transaction a stock purchase or sale?

The Form 4 shows a grant or award acquisition, not an open-market purchase or sale. Transaction code A indicates shares were awarded as compensation rather than bought or sold in the market by the director.

How many ARTIVION (AORT) shares does Elizabeth Hoff hold after this award?

Following the 7,576-share grant, Elizabeth A. Hoff directly holds 34,765 shares of ARTIVION common stock. This figure reflects her position after the reported transaction and helps gauge the size of the grant relative to her total holdings.

What are the vesting terms of the ARTIVION (AORT) restricted stock award?

The footnote states the restricted stock award vests on May 18, 2027 under ARTIVION’s Equity and Cash Incentive Plan. Vesting means she fully earns the shares over time, typically subject to continued service or other plan conditions.

Does the ARTIVION (AORT) Form 4 indicate any option exercises or derivative trades?

No derivative transactions are shown in this Form 4. The filing reports only a non-derivative grant of common stock, with no option exercises, warrant conversions, or other derivative activity disclosed in the derivativeSummary section.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hoff Elizabeth A

(Last) (First) (Middle)

ARTIVION INC

1655 ROBERTS BLVD NW

(Street)

KENNESAW GEORGIA 30144

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/18/2026		A		7,576(1)	A	$0	34,765	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

Remarks:

	/s/ Elizabeth A. Hoff	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)